Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129-1141).

van Overdam, Koen A; Sebag, Jerry

Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129-1141).

van Overdam, Koen A; Sebag, Jerry.

Afiliação

van Overdam KA; Department of Vitreoretinal Surgery, The Rotterdam Eye Hospital, Rotterdam, the Netherlands; The Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands. Electronic address: K.vanOverdam@oogziekenhuis.nl.
Sebag J; VMR Institute for Vitreous Macula Retina, Huntington Beach, California; Doheny Eye Institute, Geffen School of Medicine, UCLA, Los Angeles, California.

Ophthalmology ; 130(6): e21, 2023 06.

Article em En | MEDLINE | ID: mdl-37210149

Assuntos

Descolamento Retiniano; Vitreorretinopatia Proliferativa; Humanos; Heparina/uso terapêutico; Vitreorretinopatia Proliferativa/tratamento farmacológico; Vitreorretinopatia Proliferativa/prevenção & controle; Fluoruracila/uso terapêutico; Descolamento Retiniano/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descolamento Retiniano / Vitreorretinopatia Proliferativa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google